News

Forest Laboratories and Glenmark Pharmaceuticals, a subsidiary of Glenmark Pharmaceuticals India (GPL) have announced top-line results from a phase IIb dose range finding study of Oglemilast in patients

Arena Pharmaceuticals has reported positive top-line results from the BLOSSOM (Behavioral modification and LOrcaserin Second Study for Obesity Management) trial. BLOSSOM confirms the results previously reported for the

Buck Systems, part of GEA Pharma has reported that Burkert has successfully built pneumatic-control systems. The system will be used to vibrate pharmaceutical-powder mixing and delivery systems for

In addition, should the company satisfy the criteria for initial listing on The NASDAQ Capital Market (except for bid price) as of March 15, 2010, the company will

Boston Scientific has completed patient enrollment in the workhorse portion of its PLATINUM clinical program. The trial enrolled 1,532 patients with up to two de novo lesions at

Cloud Packaging, a portfolio company of Cameron Holdings, has acquired Toll Packaging Group located in Gibson City, Illinois. Cloud packaging is a provider of a full range of

Zila has announced the completion of the merger with a subsidiary of TOLMAR Holding. Pursuant to the merger agreement between the companies, at the effective time of the

NewCardio has closed a private placement financing with institutional and other accredited investors, including members of NewCardio’s management team and board of directors, who purchased over half of

“We are extremely fortunate to have attracted someone of John Norris’ caliber,” said Stephen D. Barnhill, M.D., chairman and CEO of Health Discovery. “We expect that his extensive